GANX - Gain Therapeutics, Inc.

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	22.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+183%)	N/M	—	6.6% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-17%)	754.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9327%)	372.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4560%)	308.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3755%)	1299.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16140%)	-21.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-363%)	—	—	—	—	—
EPS Growth YoY (%)	18.8% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	11.8% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	54.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	27.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	62.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	54.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	48.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	25.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	2.6% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-44.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-53.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	2.6% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	-43.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	50.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-56.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-11.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-23.8% Weak ↓ Weak Declining Year-over-year change in net income	-20.4% Weak ↓ Weak Declining Year-over-year change in net income	-17.8% Weak ↓ Weak Declining Year-over-year change in net income	28.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.9% Weak ↓ Weak Declining Year-over-year change in net income	20.2% Good ↑ Good Improving Year-over-year change in net income	4.9% Caution → Caution Stable Year-over-year change in net income	-5.9% Weak ↓ Weak Declining Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	-1.1% Weak ↑ Weak Improving Year-over-year change in net income	-3.5% Weak ↑ Weak Improving Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	-57.0% Weak ↓ Weak Declining Year-over-year change in net income	-45.2% Weak ↓ Weak Declining Year-over-year change in net income	2.3% Caution ↑ Caution Improving Year-over-year change in net income	-43.0% Weak ↑ Weak Improving Year-over-year change in net income	-33.6% Weak ↑ Weak Improving Year-over-year change in net income	-94.5% Weak ↑ Weak Improving Year-over-year change in net income	-487.1% Weak ↓ Weak Declining Year-over-year change in net income	-554.6% Weak Weak Year-over-year change in net income	-319.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	16.0% Good Good Year-over-year change in free cash flow	—	—	—	33.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	43.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-71.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	102.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	-3.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-11.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-15.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.20x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.29x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.30x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-38.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-84.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-125.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-72.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-66.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	112.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-729.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-28.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-42.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-16.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-40.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-367%)	-24.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-89.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-696%)	-157.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1148%)	-78.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-623%)	-51.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-442%)	-50.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-436%)	-69.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-561%)	-46.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-410%)	-37.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-350%)	-64.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-529%)	-69.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-562%)	-33.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-326%)	-24.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-20.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-18.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-10.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-9.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-12.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-8.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-5.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-26.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-10.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	114.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+660%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.07x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	0.12x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	0.07x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.07x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1991.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-351.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-16.17M	$-20.44M	$-8.38M	$-6.24M	$-8.64M	$-10.06M	$-11.56M	$-16.45M	$-10.13M	$-11.35M	$-3.73M	$-5.74M	$-5.40M	$-6.82M	$-10.29M	$-13.68M	$-33.69M	$-36.29M	$-40.36M	$-42.52M	$-45.92M	$-6.78M	—	—	—	—
Debt / EBITDA (x)	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.13x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.28x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.44x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	—	$0.01	$0.00	—	$0.00	$0.01	—	—	$0.00	$0.00	—	—
Basic EPS, GAAP (USD)	$-0.13	$-0.11	$-0.15	$-0.19	$-0.16	$-0.11	$-0.17	$-0.42	$-0.22	$-0.29	$-0.37	$-0.62	$-0.43	$-0.39	$-0.38	$-0.43	$-0.28	$-0.26	$-0.39	$-0.30	—	$-0.53	$-0.25	$-0.27	—	—
Free Cash Flow per Share (USD)	$-0.11	—	$-0.14	$-0.17	$-0.13	—	—	—	$-0.20	—	—	—	$-0.35	—	—	—	$-0.21	—	—	—	—	—	$-0.24	$-0.21	—	—
Book Value per Share (USD)	$0.33	$0.44	$0.16	$0.12	$0.20	$0.27	$0.34	$0.47	$0.48	$0.78	$0.57	$0.88	$1.25	$1.59	$1.91	$2.27	$2.68	$2.93	$3.16	$3.48	$3.74	$1.75	$2.44	$-0.24	—	—
Tangible Book Value per Share (USD)	$0.33	$0.44	$0.16	$0.12	$0.20	$0.27	$0.34	$0.47	$0.48	$0.78	$0.57	$0.88	$1.25	$1.59	$1.91	$2.27	$2.68	$2.93	$3.16	$3.48	$3.74	$1.75	$2.44	$-0.24	—	—
Basic Weighted Avg Shares (shares)	42.23M	—	35.00M	30.34M	28.69M	—	26.53M	19.22M	17.98M	—	12.70M	12.39M	11.94M	—	11.88M	11.88M	11.88M	—	11.88M	11.88M	—	—	3.20M	1.98M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$14.34M	$18.88M	$6.35M	$4.11M	$6.12M	$7.69M	$9.15M	$12.02M	$8.86M	$12.83M	$7.48M	$11.72M	$14.17M	$16.97M	$20.02M	$22.42M	$32.18M	$35.17M	$37.98M	$41.88M	$45.06M	$6.87M	—	—	—	—
LT Debt (USD)	$373.55K	$400.95K	$424.34K	$451.47K	$427.60K	$328.33K	$494.41K	$486.40K	$507.68K	$449.05K	$544.22K	$578.27K	$587.50K	$495.26K	$585.28K	$626.01K	$647.51K	$590.47K	$620.17K	$646.66K	$678.25K	$715.66K	—	—	—	—
Total Equity (USD)	$14.01M	$18.56M	$5.91M	$3.70M	$5.78M	$7.34M	$8.91M	$11.78M	$8.64M	$12.58M	$7.33M	$11.09M	$15.14M	$18.88M	$22.66M	$27.02M	$31.83M	$34.82M	$37.55M	$41.39M	$44.46M	$6.20M	$7.83M	$-476.59K	$70.40K	$-449.86K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Aug 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	$0.00	—	—	$55.18K	$0.00	—	$95.10K	$45.01K	$43.21K	$27.34K	$89.17K	$5.27K	$9.14K	$6.70K	$6.37K	$6.67K	—
Depreciation Expense (USD)	$21.30K	$28.24K	$22.82K	$22.33K	$20.66K	$21.31K	—	—	$20.53K	$23.59K	—	$17.14K	$19.24K	$18.11K	—	$6.20K	$8.21K	$5.79K	—	—	$3.40K	$2.83K	$2.38K	$2.28K	$2.10K	—
Net Income, GAAP (USD)	$-5.61M	$-4.54M	$-5.28M	$-5.81M	$-4.53M	$-3.77M	$-4.49M	$-8.14M	$-4.01M	$-4.72M	$-4.72M	$-7.69M	$-5.14M	$-4.67M	$-4.56M	$-5.09M	$-3.27M	$-3.22M	$-4.66M	$-3.56M	$-2.45M	$-1.66M	$-794.37K	$-543.36K	$-584.27K	—
Operating Cash Flow (USD)	$-4.73M	$-4.62M	$-4.93M	$-5.10M	$-3.82M	$-3.45M	—	—	$-3.59M	$-5.66M	—	—	$-4.22M	$-3.90M	—	—	$-2.45M	$-4.15M	—	—	$-2.81M	$-1.31M	$-755.02K	$-424.19K	$-752.82K	—

Gain Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare GANX with peers